Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy

Journal of Cell Biology

Volumn 207, Issue 1, 2014, Pages 139-158

  Dadgar, Sherry ^a   Wang, Zuyi ^a   Johnston, Helen ^a   Kesari, Akanchha ^a   Nagaraju, Kanneboyina ^a   Chen, Yi Wen ^a   Ashley Hill, D ^a   Partridge, Terence A ^a   Giri, Mamta ^a   Freishtat, Robert J ^a   Nazarian, Javad ^a   Xuan, Jianhua ^b   Wang, Yue ^b   Hoffman, Eric P ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b Virginia Polytechnic Institute and State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PREDNISONE; UNCLASSIFIED DRUG; VBP 15; ANTIINFLAMMATORY AGENT; DYSTROPHIN; MESSENGER RNA; PREGNANE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA; VBP15 COMPOUND;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; HUMAN TISSUE; MITOCHONDRIAL RESPIRATION; MOUSE; MUSCLE ATROPHY; MUSCLE REGENERATION; MUSCLE TISSUE; MUSCULAR DYSTROPHY; MYOFIBROSIS; NONHUMAN; PHENOTYPE; TISSUE REGENERATION; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; EMERY DREIFUSS MUSCULAR DYSTROPHY; FIBROSIS; GENETICS; INFLAMMATION; LIMB GIRDLE MUSCULAR DYSTROPHY; METABOLISM; MITOCHONDRION; PATHOLOGY; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEIN TERTIARY STRUCTURE; REGENERATION; SKELETAL MUSCLE; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL DIFFERENTIATION; CELLS, CULTURED; DYSTROPHIN; FIBROSIS; HUMANS; INFLAMMATION; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; MUSCULAR DYSTROPHY, EMERY-DREIFUSS; PREDNISONE; PREGNADIENEDIOLS; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; PROTEIN STRUCTURE, TERTIARY; REGENERATION; RNA, MESSENGER; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84908367208     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201402079     Document Type: Article

References (60)

1. Aguennouz, M., G.L. Vita, S. Messina, A. Cama, N. Lanzano, A. Ciranni, C. Rodolico, R.M. Di Giorgio, and G. Vita. 2011. Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy. Neurobiol. Aging. 32:2190-2197. http://dx.doi.org/ 10.1016/j.neurobiolaging.2010.01.008.
2. Akhurst, R.J., and A. Hata. 2012. Targeting the TGFβ signalling pathway in disease. Nat. Rev. Drug Discov. 11:790-811. http://dx.doi.org/10.1038/ nrd3810.
3. Alcala, S.E., A.S. Benton, A.M. Watson, S. Kureshi, E.M. Reeves, J. Damsker, Z. Wang, K. Nagaraju, J. Anderson, A.M. Williams, et al. 2014. Mitotic asynchrony induces transforming growth factor-β1 secretion from airway epithelium. Am. J. Respir. Cell Mol. Biol. 51:363-369. http://dx.doi.org/ 10.1165/rcmb.2013-0396OC.
4. Alexakis, C., T. Partridge, and G. Bou-Gharios. 2007. Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am. J. Physiol. Cell Physiol. 293:C661-C669. http://dx.doi.org/10.1152/ajpcell.00061.2007.
5. Bakay, M., Y.W. Chen, R. Borup, P. Zhao, K. Nagaraju, and E.P. Hoffman. 2002. Sources of variability and effect of experimental approach on expression profiling data interpretation. BMC Bioinformatics. 3:4. http:// dx.doi.org/10.1186/1471-2105-3-4.
6. Bakay, M., Z. Wang, G. Melcon, L. Schiltz, J. Xuan, P. Zhao, V. Sartorelli, J. Seo, E. Pegoraro, C. Angelini, et al. 2006. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain. 129:996-1013. http://dx.doi.org/ 10.1093/brain/awl023.
7. Baron, D., A. Magot, G. Ramstein, M. Steenman, G. Fayet, C. Chevalier, P. Jourdon, R. Houlgatte, F. Savagner, and Y. Pereon. 2011. Immune response and mitochondrial metabolism are commonly deregulated in DMD and aging skeletal muscle. PLoS ONE. 6:e26952. http://dx.doi.org/10.1371/journal.pone.0026952.
8. Bello, L., L. Piva, A. Barp, A. Taglia, E. Picillo, G. Vasco, M. Pane, S.C. Previtali, Y. Torrente, E. Gazzerro, et al. 2012. Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. Neurology. 79:159-162. http://dx.doi.org/10.1212/WNL.0b013e31825f04ea.
9. Bhattacharyya, S., K. Kelley, D.S. Melichian, Z. Tamaki, F. Fang, Y. Su, G. Feng, R.M. Pope, G.R. Budinger, G.M. Mutlu, et al. 2013. Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am. J. Pathol. 182:192-205. http://dx.doi.org/10.1016/j.ajpath.2012.09.007.
10. Blau, H.M., C. Webster, and G.K. Pavlath. 1983. Defective myoblasts identified in Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. USA. 80:4856-4860. http://dx.doi.org/10.1073/pnas.80.15.4856.
11. Bowen, T., R.H. Jenkins, and D.J. Fraser. 2013. MicroRNAs, transforming growth factor beta-1, and tissue fibrosis. J. Pathol. 229:274-285. http:// dx.doi.org/10.1002/path.4119.
12. Bushby, K., R. Finkel, D.J. Birnkrant, L.E. Case, P.R. Clemens, L. Cripe, A. Kaul, K. Kinnett, C. McDonald, S. Pandya, et al.; DMD Care Considerations Working Group. 2010. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 9:77-93. http://dx.doi.org/10.1016/S1474-4422(09)70271-6.
13. Chen, Y.W., K. Nagaraju, M. Bakay, O. McIntyre, R. Rawat, R. Shi, and E.P. Hoffman. 2005. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology. 65:826-834. http://dx.doi.org/10.1212/01.wnl.0000173836.09176.c4.
14. Chen, Y.W., R. Shi, N. Geraci, S. Shrestha, H. Gordish-Dressman, and L.M. Pachman. 2008. Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis. BMC Immunol. 9:43. http://dx.doi.org/10.1186/1471-2172-9-43.
15. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-293. http://dx.doi.org/10.1146/annurev.iy.12.040194.001355.
16. Dahiya, S., S. Bhatnagar, S.M. Hindi, C. Jiang, P.K. Paul, S. Kuang, and A. Kumar. 2011a. Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice. Hum. Mol. Genet. 20:4345-4359. http://dx.doi.org/10.1093/hmg/ddr362.
17. Dahiya, S., S. Givvimani, S. Bhatnagar, N. Qipshidze, S.C. Tyagi, and A. Kumar. 2011b. Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy. J. Immunol. 187:2723-2731. http://dx.doi.org/10.4049/jimmunol.1101342.
18. Decary, S., C.B. Hamida, V. Mouly, J.P. Barbet, F. Hentati, and G.S. Butler-Browne. 2000. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul. Disord. 10: 113-120. http://dx.doi.org/10.1016/S0960-8966(99)00093-0.
19. Dubowitz, V., and C.A. Sewry. 2007. Muscle Biopsy: A Practical Approach. Third edition. Saunders Elsevier, China. 626 pp.
20. Flanigan, K.M., E. Ceco, K.M. Lamar, Y. Kaminoh, D.M. Dunn, J.R. Mendell, W.M. King, A. Pestronk, J.M. Florence, K.D. Mathews, et al. United Dystrophinopathy Project. 2013. LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular dystrophy. Ann. Neurol. 73:481-488. http://dx.doi.org/10.1002/ana.23819.
21. Freishtat, R.J., A.M. Watson, A.S. Benton, S.F. Iqbal, D.K. Pillai, M.C. Rose, and E.P. Hoffman. 2011. Asthmatic airway epithelium is intrinsically inflammatory and mitotically dyssynchronous. Am. J. Respir. Cell Mol. Biol. 44:863-869. http://dx.doi.org/10.1165/rcmb.2010-0029OC.
22. Gaschen, F.P., E.P. Hoffman, J.R. Gorospe, E.W. Uhl, D.F. Senior, G.H. Cardinet III, and L.K. Pearce. 1992. Dystrophin deficiency causes lethal muscle hypertrophy in cats. J. Neurol. Sci. 110:149-159. http://dx.doi.org/10.1016/0022-510X(92)90022-D.
23. Heier, C.R., J.M. Damsker, Q. Yu, B.C. Dillingham, T. Huynh, J.H. Van der Meulen, A. Sali, B.K. Miller, A. Phadke, L. Scheffer, et al. 2013. VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects. EMBO Mol. Med. 5:1569-1585. http://dx.doi.org/10.1002/emmm.201302621.
24. Hoffman, E.P., R.H. Brown Jr., and L.M. Kunkel. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:919-928. http://dx.doi.org/10.1016/0092-8674(87)90579-4.
25. Hoffman, E.P., E. Reeves, J. Damsker, K. Nagaraju, J.M. McCall, E.M. Connor, and K. Bushby. 2012. Novel approaches to corticosteroid treatment in Duchenne muscular dystrophy. Phys. Med. Rehabil. Clin. N. Am. 23:821-828. http://dx.doi.org/10.1016/j.pmr.2012.08.003.
26. Holderfield, M.T., and C.C. Hughes. 2008. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ. Res. 102:637-652. http://dx.doi.org/10.1161/ CIRCRESAHA.107.167171.
27. Irizarry, R.A., D. Warren, F. Spencer, I.F. Kim, S. Biswal, B.C. Frank, E. Gabrielson, J.G. Garcia, J. Geoghegan, G. Germino, et al. 2005. Multiplelaboratory comparison of microarray platforms. Nat. Methods. 2:345-350. http://dx.doi.org/10.1038/nmeth756.
28. Karkampouna, S., P. Ten Dijke, S. Dooley, and M.K. Julio. 2012. TGFβ signaling in liver regeneration. Curr. Pharm. Des. 18:4103-4113. http://dx.doi.org/10.2174/138161212802430521.
29. Klymiuk, N., A. Blutke, A. Graf, S. Krause, K. Burkhardt, A. Wuensch, S. Krebs, B. Kessler, V. Zakhartchenko, M. Kurome, et al. 2013. Dystrophindeficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle. Hum. Mol. Genet. 22:4368-4382. http://dx.doi.org/10.1093/hmg/ddt287.
30. Koh, M.Y., and G. Powis. 2012. Passing the baton: the HIF switch. Trends Biochem. Sci. 37:364-372. http://dx.doi.org/10.1016/j.tibs.2012.06.004.
31. Kollias, H.D., and J.C. McDermott. 2008. Transforming growth factor-beta and myostatin signaling in skeletal muscle. J. Appl. Physiol. 104:579-587. http://dx.doi.org/10.1152/japplphysiol.01091.2007.
32. Kornegay, J.N., J.R. Bogan, D.J. Bogan, M.K. Childers, J. Li, P. Nghiem, D.A. Detwiler, C.A. Larsen, R.W. Grange, R.K. Bhavaraju-Sanka, et al. 2012a. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies. Mamm. Genome. 23:85-108. http://dx.doi.org/10.1007/ s00335-011-9382-y.
33. Kornegay, J.N., M.K. Childers, D.J. Bogan, J.R. Bogan, P. Nghiem, J. Wang, Z. Fan, J.F. Howard Jr., S.J. Schatzberg, J.L. Dow, et al. 2012b. The paradox of muscle hypertrophy in muscular dystrophy. Phys. Med. Rehabil. Clin. N. Am. 23:149-172. http://dx.doi.org/10.1016/j.pmr.2011.11.014.
34. Kottlors, M., and J. Kirschner. 2010. Elevated satellite cell number in Duchenne muscular dystrophy. Cell Tissue Res. 340:541-548. http://dx.doi.org/ 10.1007/s00441-010-0976-6.
35. MacDonald, E.M., and R.D. Cohn. 2012. TGFβ signaling: its role in fibrosis formation and myopathies. Curr. Opin. Rheumatol. 24:628-634. http:// dx.doi.org/10.1097/BOR.0b013e328358df34.
36. Madsen, M., J.H. Graversen, and S.K. Moestrup. 2001. Haptoglobin and CD163: captor and receptor gating hemoglobin to macrophage lysosomes. Redox Rep. 6:386-388. http://dx.doi.org/10.1179/135100001101536490.
37. Maier, F., and A. Bornemann. 1999. Comparison of the muscle fiber diameter and satellite cell frequency in human muscle biopsies. Muscle Nerve. 22: 578-583. http://dx.doi.org/10.1002/(SICI)1097-4598(199905)22:5<578:: AID-MUS5>3.0.CO;2-T.
38. Miyazaki, D., A. Nakamura, K. Fukushima, K. Yoshida, S. Takeda, and S. Ikeda. 2011. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers. Hum. Mol. Genet. 20:1787-1799. http://dx.doi.org/10.1093/hmg/ddr062.
39. Nghiem, P.P., E.P. Hoffman, P. Mittal, K.J. Brown, S.J. Schatzberg, S. Ghimbovschi, Z. Wang, and J.N. Kornegay. 2013. Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs. Am. J. Pathol. 183:1411-1424. http://dx.doi.org/10.1016/j.ajpath.2013.07.013.
40. Niimi, H., K. Pardali, M. Vanlandewijck, C.H. Heldin, and A. Moustakas. 2007. Notch signaling is necessary for epithelial growth arrest by TGF-β. J. Cell Biol. 176:695-707. http://dx.doi.org/10.1083/jcb.200612129.
41. Oexle, K., A. Zwirner, K. Freudenberg, A. Kohlschütter, and A. Speer. 1997. Examination of telomere lengths in muscle tissue casts doubt on replicative aging as cause of progression in Duchenne muscular dystrophy. Pediatr. Res. 42:226-231. http://dx.doi.org/10.1203/00006450-199708000-00016.
42. Pegoraro, E., E.P. Hoffman, L. Piva, B.F. Gavassini, S. Cagnin, M. Ermani, L. Bello, G. Soraru, B. Pacchioni, M.D. Bonifati, et al.; Cooperative International Neuromuscular Research Group. 2011. SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology. 76:219-226. http://dx.doi.org/10.1212/WNL.0b013e318207afeb.
43. Philippou, A., M. Maridaki, and M. Koutsilieris. 2008. The role of urokinasetype plasminogen activator (uPA) and transforming growth factor beta 1 (TGFbeta1) in muscle regeneration. In Vivo. 22:735-750.
44. Sali, A., A.D. Guerron, H. Gordish-Dressman, C.F. Spurney, M. Iantorno, E.P. Hoffman, and K. Nagaraju. 2012. Glucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouse. PLoS ONE. 7:e34204. http://dx.doi.org/10.1371/journal.pone.0034204.
45. Seo, J., and E.P. Hoffman. 2006. Probe set algorithms: is there a rational best bet? BMC Bioinformatics. 7:395. http://dx.doi.org/10.1186/1471-2105-7-395.
46. Seo, J., M. Bakay, Y.W. Chen, S. Hilmer, B. Shneiderman, and E.P. Hoffman. 2004. Interactively optimizing signal-to-noise ratios in expression profiling: project-specific algorithm selection and detection p-value weighting in Affymetrix microarrays. Bioinformatics. 20:2534-2544. http://dx.doi.org/10.1093/bioinformatics/bth280.
47. Seo, J., H. Gordish-Dressman, and E.P. Hoffman. 2006. An interactive power analysis tool for microarray hypothesis testing and generation. Bioinformatics. 22:808-814. http://dx.doi.org/10.1093/bioinformatics/btk052.
48. Serrano, A.L., C.J. Mann, B. Vidal, E. Ardite, E. Perdiguero, and P. Muñoz-Cánoves. 2011. Cellular and molecular mechanisms regulating fibrosis in skeletal muscle repair and disease. Curr. Top. Dev. Biol. 96:167-201. http://dx.doi.org/10.1016/B978-0-12-385940-2.00007-3.
49. Solovjov, D.A., E. Pluskota, and E.F. Plow. 2005. Distinct roles for the a and β subunits in the functions of integrin aMb2. J. Biol. Chem. 280:1336-1345. http://dx.doi.org/10.1074/jbc.M406968200.
50. Tezak, Z., E.P. Hoffman, J.L. Lutz, T.O. Fedczyna, D. Stephan, E.G. Bremer, I. Krasnoselska-Riz, A. Kumar, and L.M. Pachman. 2002. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J. Immunol. 168:4154-4163. http://dx.doi.org/10.4049/jimmunol.168.8.4154.
51. Tumor Analysis Best Practices Working Group. 2004. Expression profiling- best practices for data generation and interpretation in clinical trials. Nat. Rev. Genet. 5:229-237. http://dx.doi.org/10.1038/nrg1297.
52. Villalta, S.A., H.X. Nguyen, B. Deng, T. Gotoh, and J.G. Tidball. 2009. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet. 18:482-496. http://dx.doi.org/10.1093/hmg/ddn376.
53. Wang, J., H. Li, Y. Zhu, M. Yousef, M. Nebozhyn, M. Showe, L. Showe, J. Xuan, R. Clarke, and Y. Wang. 2007. VISDA: an open-source caBIG analytical tool for data clustering and beyond. Bioinformatics. 23:2024-2027. http://dx.doi.org/10.1093/bioinformatics/btm290.
54. Wang, Y., L. Luo, M.T. Freedman, and S.Y. Kung. 2000. Probabilistic principal component subspaces: a hierarchical finite mixture model for data visualization. IEEE Trans. Neural Netw. 11:625-636. http://dx.doi.org/10.1109/72.846734.
55. Watkins, S.C., and M.J. Cullen. 1986. A quantitative comparison of satellite cell ultrastructure in Duchenne muscular dystrophy, polymyositis, and normal controls. Muscle Nerve. 9:724-730. http://dx.doi.org/10.1002/ mus.880090808.
56. Watkins, S.C., and M.J. Cullen. 1988. A quantitative study of myonuclear and satellite cell nuclear size in Duchenne's muscular dystrophy, polymyositis and normal human skeletal muscle. Anat. Rec. 222:6-11. http://dx.doi.org/10.1002/ar.1092220103.
57. Zhao, P., and E.P. Hoffman. 2004. Embryonic myogenesis pathways in muscle regeneration. Dev. Dyn. 229:380-392. http://dx.doi.org/10.1002/dvdy.10457.
58. Zhao, P., J. Seo, Z. Wang, Y. Wang, B. Shneiderman, and E.P. Hoffman. 2003. In vivo filtering of in vitro expression data reveals MyoD targets. C. R. Biol. 326:1049-1065. http://dx.doi.org/10.1016/j.crvi.2003.09.035.
59. Zhao, P., G. Caretti, S. Mitchell, W.L. McKeehan, A.L. Boskey, L.M. Pachman, V. Sartorelli, and E.P. Hoffman. 2006. Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway. J. Biol. Chem. 281:429-438. http://dx.doi.org/ 10.1074/jbc.M507440200.
60. Zhu, Y., H. Li, D.J. Miller, Z. Wang, J. Xuan, R. Clarke, E.P. Hoffman, and Y. Wang. 2008. caBIG VISDA: modeling, visualization, and discovery for cluster analysis of genomic data. BMC Bioinformatics. 9:383. http:// dx.doi.org/10.1186/1471-2105-9-383.